OnKure Therapeutics, Inc. SEC filings OKUR

OnKure Therapeutics, Inc. has 404 filings in SEC EDGAR's recent list, going back to Jan 8, 2018. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

OnKure Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 7, 2026 —
4 Insider transaction Sep 23, 2026 Sep 21, 2026
4 Insider transaction Sep 23, 2026 Sep 21, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4/A Filing Aug 13, 2026 Aug 7, 2026
8-K Current report
Officer or director change
Aug 13, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 10, 2026 —
424B5 Prospectus supplement Aug 4, 2026 —
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
4 Insider transaction Jun 8, 2026 Jun 4, 2026
S-8 Employee stock plan registration Jun 5, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 4, 2026 Jun 3, 2026
SCHEDULE 13G Ownership over 5% (passive) May 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
EFFECT Filing May 4, 2026 —
CORRESP Letter to the SEC Apr 30, 2026 —
UPLOAD Letter from the SEC Apr 30, 2026 —
S-3 Shelf registration Apr 24, 2026 —
DEFA14A Additional proxy material Apr 21, 2026 —
DEF 14A Proxy statement Apr 21, 2026 Jun 3, 2026
ARS Annual report to shareholders Apr 21, 2026 Dec 31, 2025
3 Initial insider ownership Apr 7, 2026 Mar 31, 2026
SCHEDULE 13D Ownership over 5% (active) Apr 7, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 7, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 7, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 7, 2026 —
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 1, 2026 Mar 31, 2026
3 Initial insider ownership Apr 1, 2026 Mar 31, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 1, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
Mar 30, 2026 Mar 27, 2026
4 Insider transaction Mar 24, 2026 Mar 23, 2026
4 Insider transaction Mar 24, 2026 Mar 23, 2026
S-8 Employee stock plan registration Mar 12, 2026 —
10-K Annual report Mar 12, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 12, 2026 Mar 12, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 30, 2026 —
4 Insider transaction Jan 2, 2026 Dec 31, 2025
4 Insider transaction Jan 2, 2026 Dec 31, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 22, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 28, 2025 —
424B3 Prospectus Nov 21, 2025 —
EFFECT Filing Nov 18, 2025 —
POS AM Filing Nov 6, 2025 —
S-3 Shelf registration Nov 6, 2025 —
424B3 Prospectus Nov 6, 2025 —
8-K Current report
Material agreement
Nov 6, 2025 Nov 6, 2025
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Sep 24, 2025 Sep 22, 2025
4 Insider transaction Sep 24, 2025 Sep 22, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
424B3 Prospectus Aug 12, 2025 —
4 Insider transaction Jul 2, 2025 Jun 30, 2025
4 Insider transaction Jul 2, 2025 Jun 30, 2025
8-K Current report
Regulation FD disclosure
Jun 26, 2025 Jun 26, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction Jun 25, 2025 Jun 23, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) May 30, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 29, 2025 —
424B3 Prospectus May 28, 2025 —
8-K Current report
Shareholder vote results
May 28, 2025 May 27, 2025
3 Initial insider ownership May 27, 2025 May 15, 2025
SCHEDULE 13D Ownership over 5% (active) May 22, 2025 —
4 Insider transaction May 19, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 19, 2025 —
4 Insider transaction May 14, 2025 May 12, 2025
424B3 Prospectus May 6, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
DEFA14A Additional proxy material Apr 16, 2025 —
DEF 14A Proxy statement Apr 16, 2025 May 27, 2025
ARS Annual report to shareholders Apr 16, 2025 Dec 31, 2024
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
424B3 Prospectus Mar 24, 2025 —
EFFECT Filing Mar 21, 2025 —
POS AM Filing Mar 20, 2025 —
S-8 Employee stock plan registration Mar 10, 2025 —
424B3 Prospectus Mar 10, 2025 —
8-K Current report
Results of operations
Mar 10, 2025 Mar 10, 2025
10-K Annual report Mar 10, 2025 Dec 31, 2024
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 6, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jan 31, 2025 —
4 Insider transaction Jan 29, 2025 Jan 27, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 21, 2025 —
424B3 Prospectus Dec 10, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Dec 10, 2024 Dec 10, 2024
S-8 Employee stock plan registration Dec 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
424B3 Prospectus Nov 7, 2024 —
8-K Current report
Auditor change, Other events
Nov 7, 2024 Nov 7, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
424B3 Prospectus Oct 31, 2024 —
EFFECT Filing Oct 30, 2024 —
CORRESP Letter to the SEC Oct 28, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 28, 2024 —
UPLOAD Letter from the SEC Oct 25, 2024 —
S-1 Registration statement Oct 23, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 23, 2024 —
D Filing Oct 21, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 16, 2024 —
3 Initial insider ownership Oct 15, 2024 Oct 4, 2024
SC 13G Ownership over 5% (passive) Oct 11, 2024 —
SC 13G Ownership over 5% (passive) Oct 11, 2024 —
SC 13G Ownership over 5% (passive) Oct 11, 2024 —
SC 13G Ownership over 5% (passive) Oct 11, 2024 —
SC 13G Ownership over 5% (passive) Oct 10, 2024 —
SC 13D/A Amended ownership over 5% (active) Oct 10, 2024 —
3 Initial insider ownership Oct 9, 2024 Oct 4, 2024
SC 13G Ownership over 5% (passive) Oct 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 9, 2024 —
4 Insider transaction Oct 9, 2024 Oct 7, 2024
SC 13D/A Amended ownership over 5% (active) Oct 8, 2024 —
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
4 Insider transaction Oct 8, 2024 Oct 4, 2024
3 Initial insider ownership Oct 8, 2024 Oct 4, 2024
3 Initial insider ownership Oct 8, 2024 Oct 4, 2024
3 Initial insider ownership Oct 8, 2024 Oct 4, 2024
3 Initial insider ownership Oct 8, 2024 Oct 4, 2024
3 Initial insider ownership Oct 8, 2024 Oct 4, 2024
3 Initial insider ownership Oct 8, 2024 Oct 4, 2024
3 Initial insider ownership Oct 8, 2024 Oct 4, 2024
3 Initial insider ownership Oct 8, 2024 Oct 4, 2024
8-K Current report
Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Oct 8, 2024 Oct 4, 2024
425 Filing Oct 2, 2024 —
8-K Current report
Shareholder vote results
Oct 2, 2024 Sep 26, 2024
SC 13G Ownership over 5% (passive) Sep 26, 2024 —
4 Insider transaction Sep 26, 2024 Sep 24, 2024
425 Filing Sep 20, 2024 —
8-K Current report
Other events
Sep 20, 2024 Sep 20, 2024
4 Insider transaction Sep 19, 2024 Sep 17, 2024
4 Insider transaction Sep 16, 2024 Sep 12, 2024
8-K Current report
Officer or director change
Sep 13, 2024 Sep 9, 2024
EFFECT Filing Aug 26, 2024 —
424B3 Prospectus Aug 26, 2024 —
S-4/A Filing Aug 26, 2024 —
CORRESP Letter to the SEC Aug 23, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OKUR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boulder, CO
SEC filer status
, Emerging growth company
SEC CIK
1637715
Former names
Reneo Pharmaceuticals, Inc. (until Oct 2, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.